Invention Grant
- Patent Title: Topical composition
-
Application No.: US16083802Application Date: 2017-03-09
-
Publication No.: US11065290B2Publication Date: 2021-07-20
- Inventor: Michael-John Joseph Barry
- Applicant: BIOPHARM NZ LIMITED
- Applicant Address: NZ Hamilton
- Assignee: BIOPHARM NZ LIMITED
- Current Assignee: BIOPHARM NZ LIMITED
- Current Assignee Address: NZ Hamilton
- Agency: Stites & Harbison, PLLC
- Agent Stephen J. Weyer, Esq.
- Priority: ZA2016/00677 20160309
- International Application: PCT/IB2017/051388 WO 20170309
- International Announcement: WO2017/153943 WO 20170914
- Main IPC: A61K36/185
- IPC: A61K36/185 ; A61K36/48 ; A61K9/00 ; A61K36/36 ; A61Q19/00 ; A61K9/06 ; A61K8/9789 ; A61P17/10 ; A61P17/06 ; A61P17/02 ; A61P31/04 ; A61P31/10 ; A61K8/34 ; A61K8/365 ; A61K8/46 ; A61K8/67 ; A61K8/73 ; A61K47/10 ; A61K47/12 ; A61K47/18 ; A61K47/20 ; A61K47/46 ; A61Q5/02 ; A61Q19/10

Abstract:
The invention discloses a therapeutic topical composition, includes an extract of Galenia Africana having anti-microbial and anti-oxidant action. The composition includes rooibos and/or an extract from rooibos tea plant. The composition is adapted for regenerating skin, stimulating cyto-keratin production, treating human external fungal infections and/or conditions, human skin bacterial conditions, psoriasis, psoriasis plaque, dandruff, acne, bacterial acnes, eczema, athletes' foot, nappy rash, baby rash and/or lesions and/or being used for anti-septic wound treatment, and/or treating Propionibacterium acnes and/or staphylococcus epidermidis.
Public/Granted literature
- US20190083562A1 TOPICAL COMPOSITION Public/Granted day:2019-03-21
Information query